Loading data for PCRX — first visit, this takes a few seconds.
Pacira BioSciences Inc. (PCRX)
NasdaqGS: PCRX
· Real-Time Price · USD
24.67
+0.84 (3.52%)
At close: Aug 24, 2026, 8:00 PM
24.86
+0.00%
After-hours: 5:31 PM
The price, the headline numbers and the latest news, in one place.
Pacira BioSciences Inc. (PCRX) Stock Price, Analysis & Data
3.52% (1D)
No data available
| Bid | 17.59 |
| Market Cap | 990.97M |
| Revenue (ttm) | 746.16M |
| Net Income (ttm) | 14.64M |
| 0.27 | |
| 0.35 | |
| 71.03 | |
| 7.21 | |
| P/B (ttm) | 1.47 |
| P/S (ttm) | 1.31 |
| Earnings Date | Nov 5, 2026 |
| Ask | 30.59 |
| Volume | 421,085 |
| Avg. Volume (20D) | 551,837 |
| Open | 23.91 |
| Previous Close | 23.83 |
| Day's Range | 23.66 - 24.72 |
| 52-Week Range | 18.80 - 27.66 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About PCRX
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and kne...
Sector Healthcare
IPO Date Feb 3, 2011
Employees 825
Stock Exchange NasdaqGS
Ticker Symbol PCRX
Website https://www.pacira.com
Financial Performance
In 2025, Pacira BioSciences's revenue was 726.41M, an increase of 3.63% compared to the previous year's 700.97M. Earnings were 7.03M, a decrease of -107.07%.
Financial StatementsEarnings Surprise
Pacira BioSciences has released their quarterly earnings on Aug 4, 2026:
- Revenue of $192.4M misses estimates by $0, with 6.24% YoY growth.
- EPS of 0.73 exceeds estimates by 0.08, with -1.35% YoY decline.
Pacira BioSciences Inc. is scheduled to release its earnings on Nov 5, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
